Home
>
Dr Reddys Laboratories Ltd Financials

Dr Reddys Laboratories Ltd Financial Statement

Dr Reddys Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

(Rs. CR)	Mar 2024	Dec 2023	Sep 2023
Revenue	5,317.5	4,330.6	5,061.8
Operating Expense	3,726.2	3,446.7	3,209.6
Net Profit	1,034.8	475.2	1,192.6
Net Profit Margin	19.46	10.97	23.56
Earning Per Share	62.14	28.55	71.68
EBIDTA	1,557.1	884.1	1,840.2
Effective Tax Rate	16.98	17.75	21.38

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

5,317.5

3,726.2

1,034.8

19.46

62.14

1,557.1

16.98

4,330.6

3,446.7

475.2

10.97

28.55

884.1

17.75

5,061.8

3,209.6

1,192.6

23.56

71.68

1,840.2

21.38

Dr Reddys Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	24,669.7	21,545.2	19,047.5
Operating Expenses Annual	18,320.7	17,777.5	15,177.6
Operating Profit Annual	7,441.5	4,322.4	4,209.3
Interest Annual	142.8	95.8	97
Depreciation	859.7	814.4	851
Net Profit Annual	4,507.3	2,182.5	1,951.6
Tax Annual	1,541.2	878.9	931.9

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

24,669.7

18,320.7

7,441.5

142.8

859.7

4,507.3

1,541.2

21,545.2

17,777.5

4,322.4

95.8

814.4

2,182.5

878.9

19,047.5

15,177.6

4,209.3

851

1,951.6

931.9

Dr Reddys Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	1,485.2	1,482	196.2
Cash Flow from Operations	5,887.5	2,810.8	3,570.3
Cash Flow from Investing	-4,108.7	-2,565.4	-2,254.7
Cash Flow from Financing	-2,686.1	-242.2	-29.8
Cash Flow at the End	577.9	1,485.2	1,482

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

1,485.2

5,887.5

-4,108.7

-2,686.1

577.9

1,482

2,810.8

-2,565.4

-242.2

1,485.2

196.2

3,570.3

-2,254.7

-29.8

1,482

Dr Reddys Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	30.16	20.06	22.1
PBIT Margin (%)	25.1	14.65	15.65
PBT Margin (%)	24.84	14.42	15.42
Net PROFIT Margin (%)	15.4	11.27	16.38
Return On Networth / Equity (%)	21.21	11.84	11.74
Return On Networth /Employed(%)	25.99	14.46	15.29
Return On Assets (%)	16.02	11.16	16.05
Total Debt / Equity(X)	0.06	0.1	0.08
Asset Turnover Ratio (%)	1.04	0.99	0.98

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

30.16

25.1

24.84

15.4

21.21

25.99

16.02

0.06

1.04

20.06

14.65

14.42

11.27

11.84

14.46

11.16

0.1

0.99

22.1

15.65

15.42

16.38

11.74

15.29

16.05

0.08

0.98

Dr Reddys Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated

Standalone

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	9,274	8,135.3	8,816.9
Total Current Assets Annual	20,425.5	17,782.3	14,550.3
Non Current Assets Annual	11,859.6	11,964.6	12,066.5
Total Shareholders Funds Annual	23,286.1	19,212.4	17,641.7
Total Assets Annual	32,285.1	29,746.9	26,616.8

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

9,274

20,425.5

11,859.6

23,286.1

32,285.1

8,135.3

17,782.3

11,964.6

19,212.4

29,746.9

8,816.9

14,550.3

12,066.5

17,641.7

26,616.8

Dr Reddys Laboratories Ltd Earning Calls

Mar 2024

EPS beaten by 0.17 %

Open Demat Account

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

Get Your FAQs Right

What is Dr Reddys Laboratories Ltd's share capital?

As of May 20, 2024, Dr Reddys Laboratories Ltd has a market capitalization of 1,02,679.14 Cr. Value Research classifies it as a Large-Cap company.

Is Dr Reddys Laboratories Ltd debt-free?

Yes, Dr Reddys Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.07.

What is Dr Reddys Laboratories Ltd's total revenue?

In FY 2023, Dr Reddys Laboratories Ltd recorded a total revenue of approximately 27,916.4 Cr marking a significant milestone in the company's financial performance.

What is the future growth of Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..

What is the PE Ratio of Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd's current PE ratio is 18.41.

What is Dr Reddys Laboratories Ltd's Return on Capital Employed (ROCE)?

Dr Reddys Laboratories Ltd's ROCE averaged 21.0% from the FY ending March 2022 to 2024, with a median of 24.1%. It peaked at 24.9% in March 2023, reflecting strong capital efficiency over the period..

What is the latest EBIT (Earnings Before Interest and Taxes) of Dr Reddys Laboratories Ltd?

Dr Reddys Laboratories Ltd's latest EBIT is Rs. 7,372.1 Cr, surpassing the average EBIT of Rs. 5,573.53 Cr over the 5 years..